Sinovac Biotech Co., Ltd

Related records

Trials (92)

• A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine
• A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old
• A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
• A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines
• A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants
• A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants
• A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population
• A Clinical Trial With Influenza A/H1N1 Vaccines
• A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
• A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine
• A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
• A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants
• A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
• A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine
• Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia
• An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
• An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
• An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses
• An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants
• Booster Dose of sIPV Co-administered With MMR and HepA-I.